Spagnuolo et al. reported that reduction of sumoylation in S100A4 would decrease its nuclear import brought by low dose paclitaxel, leading to halts of tumor invasiveness and hematogenous metastatization [4]. This evidence concerns the gene S100A4 and neoplasm.